---
schema_version: "secwatch.filing_event.v1"
accession: "0001746473-25-000105"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:19:58.554146+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve charter amendment to limit officer liability; elect three Class II directors

## Summary
- Amendment limiting officer liability approved with 35.2M For, 3.8M Against, 881.7K Abstain; filed June 9, 2025.
- Class II directors elected: John Curnutte (34.5M For), Katharine Knobil (26.7M For), Thomas McCourt (31.6M For).
- Advisory say-on-pay passed with 30.0M For, 8.9M Against, 910.9K Abstain.
- Ratification of Deloitte as auditor for FY2025 approved with 50.8M For, 506K Against, 931K Abstain.
- Broker non-votes totaled 12.35M shares on all proposals except auditor ratification.

## SEC filing metadata
- accession: 0001746473-25-000105
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000174647325000105/0001746473-25-000105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000174647325000105/plrx-20250605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001746473-25-000105
- JSON: https://secwatch.observer/filing/0001746473-25-000105.json
- Plain text: https://secwatch.observer/filing/0001746473-25-000105.txt

## Key facts
- Governance Changes
  PLIANT THERAPEUTICS, INC.: Stockholders approved an amendment to the Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law, effective June 9, 2025 (effective 2025-06-09).
  - Change: charter amendment
  - Effective: 2025-06-09
  source text: At the Annual Meeting, the stockholders of the Company approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company, as permitted by Delaware law (the “Amendment”), as further described in the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on April 23, 2025 (the “Proxy Statement”). The Amendment became effective upon the filing of a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on June 9, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1746473/000174647325000105/0001746473-25-000105-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.